Foresee Pharmaceuticals Co., Ltd. announced the appointment of Lawrence Gan to the position of Chief Executive Officer (CEO), effective on August 1, 2017. Lawrence Gan will lead the company's global strategy including portfolio planning, technology and platform research, preclinical and clinical development, commercialization, M&A, and capital market activities. Dr. Ben Chien, Founder and Executive Chairman, will work closely with Dr. Gan to ensure a seamless transition and consistent executions of corporate strategies. Before joining Foresee, Dr. Lawrence Gan was President and CEO of the Development Center for Biotechnology (DCB) in Taipei, Taiwan.